Lead Product(s) : N-Acetylglucosamine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)
Details : N-Acetyl Glucosamine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Coronavirus.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
January 12, 2021
Lead Product(s) : N-Acetylglucosamine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
